Category: Clinical trials

Aerie Pharmaceuticals Completes Enrollment of Rocket 4 Phase 3 Clinical Trial of Rhopressa (netarsudil ophthalmic solution) 0.02%

IRVINE, Calif., June 16, 2016 --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced...

Pfizer Announces Final Results from Inotuzumab Ozogamicin Pivotal Phase 3 Study in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

June 12, 2016 - Pfizer Inc. (NYSE:PFE) today announced the publication of findings from the Phase 3 INO-VATE ALL study in the online issue of The New England Journal of Medicine. The study, also known as Study 1022, is an open-label, randomized,...

Amgen Announces Erenumab (AMG 334) Significantly Reduces Patients’ Monthly Migraine Days In Phase 2 Study For The Prevention Of Chronic Migraine

THOUSAND OAKS, Calif., June 8, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced positive top-line results from the global Phase 2 study evaluating the efficacy and safety of erenumab (AMG 334) in chronic migraine prevention. The study met...